Future of mRNA CAR-T Therapies for Allergic Diseases

  Allergic diseases are affecting millions of people worldwide, from food allergies and asthma to severe immune reactions triggered by environmental allergens. Traditional treatments such as antihistamines, steroids, and immunotherapy help manage symptoms but often fail to provide long-term relief.   Today, advanced biotechnology is opening the door to more targeted solutions. One of the most promising innovations is mRNA CAR-T therapies for allergic diseases , a next-generation approach that could transform the way allergies are treated.   Understanding mRNA CAR-T Therapies for Allergic Diseases   CAR-T therapy emerged as a groundbreaking cancer immunotherapy. Scientists engineered a patient’s T cells to recognize and destroy cancer cells. Now researchers are adapting this technology for immune-related conditions, including allergies.   In mRNA CAR-T therapies for allergic diseases , messenger RNA (mRNA) is used to temporarily program T cells to...